{"version":"1.0","provider_name":"PTC Therapeutics (United States)","provider_url":"https:\/\/www.ptcbio.com","title":"Improving Access for Rare Disease Patients through Cross-Border Healthcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"hKxvr0MNlg\"><a href=\"https:\/\/www.ptcbio.com\/posts\/improving-access-for-rare-disease-patients-through-cross-border-healthcare\/\">Improving Access for Rare Disease Patients through Cross-Border Healthcare<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.ptcbio.com\/posts\/improving-access-for-rare-disease-patients-through-cross-border-healthcare\/embed\/#?secret=hKxvr0MNlg\" width=\"600\" height=\"338\" title=\"&#8220;Improving Access for Rare Disease Patients through Cross-Border Healthcare&#8221; &#8212; PTC Therapeutics (United States)\" data-secret=\"hKxvr0MNlg\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.ptcbio.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.ptcbio.com\/wp-content\/uploads\/sites\/2\/2022\/12\/europe.jpg","thumbnail_width":1440,"thumbnail_height":500,"description":"Treatments for rare diseases, such as gene therapies, are complex, requiring a high level of clinical expertise and often administration in a specialist center. As these diseases are not common, treatments and specialist centers are not accessible in every country in Europe. Patients with rare diseases may therefore have to cross geographical borders to receive&hellip;"}